Approval for the dakocytomation egfr pharmdx.  The device is indicated for:  the egfr pharmdx assay is a qualitative immunohistochemical (ihc) kit system to identify epidermal growth factor receptor (egfr) expression in normal and neoplastic tissues routinely-fixed for histological evaluation.  Egfr pharmdx specifically detects the egfr (her1) protein in egfr-expressing cells.  Egfr pharmdx is indicated as an aid in identifying colorectal cancer patients eligible for treatment with erbitux (cetuximab).